ArticleClinical, cosmetic and investigational dermatology2025
Subcutaneous Panniculitis-Like T-Cell Lymphoma in Children: Two Case Reports.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma derived from cytotoxic αβ T cells, clinically and histopathologically resembling inflammatory diseases of adipose tissue, particularly lupus panniculitis. It accounts for <1% of all non-Hodgkin's lymphomas, with approximately 20% of cases occurring in children. The main aim of this paper was to present two pediatric cases of SPTCL, highlighting the diagnostic challenges involved. The first patient, a 5-year-9-month-old boy, was admitted with a 15 cm infiltrative lesion on the left thigh, previously misdiagnosed and unsuccessfully treated with antibiotics. Imaging revealed an infiltrate resembling lymphedema. A biopsy confirmed SPTCL with a typical immunophenotype. The patient received EURO-LB 02 protocol therapy for peripheral T-cell lymphoma, complicated by pancytopenia, respiratory infection, and polyneuropathy. Post-treatment follow-up showed lesion regression, with residual subcutaneous atrophy (5 cm). The second patient, a 7-year-old girl, presented with a 10 cm inflammatory lesion on the left thigh and systemic symptoms. Imaging and histopathology confirmed the diagnosis. She was treated with the same protocol. Three years later, disease recurrence occurred on the left forearm, managed with alemtuzumab and methotrexate. Both patients remain under outpatient follow-up. Despite its rarity, SPTCL poses a significant diagnostic challenge in children. Accurate differentiation and early diagnosis are crucial for prompt and effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.